Inventor · disambiguated record
Christine Gaucher
Also filed as: GAUCHER CHRISTINE
11 granted patents·6 pending applications·67 citations·filing 2003–2017
88Inventor score
Files withLAB FRANCAIS DU FRACTIONNEMENT8LFB BIOTECHNOLOGIES5BOUREL DOMINIQUE1DE ROMEUF CHRISTOPHE1GAUCHER CHRISTINE1
Top patents by PatentIndex Score
17 records- 0190US9873745B2Antibody method for treatment of a disease in which the target cells are cells which express CD20LAB FRANCAIS DU FRACTIONNEMENT·Filed 2015·Granted Jan 23, 2018·7 cites·17 claims
- 0290US7713524B2Use of ADCC-optimized antibodies for treating low-responder patientsLFB BIOTECHNOLOGIES·Filed 2004·Granted May 11, 2010·34 cites·10 claims
- 0385US9234045B2Monoclonal antibody directed against CD20 antigenDE ROMEUF CHRISTOPHE·Filed 2005·Granted Jan 12, 2016·10 cites·12 claims
- 0483US8501171B2Use of ADCC-optimized antibodies for treating weak patientsBOUREL DOMINIQUE·Filed 2010·Granted Aug 6, 2013·9 cites·10 claims
- 0573US10179816B2Pharmaceutical compositions comprising an antibody which binds the human anti-Müllerian hormone receptor type IILABORATOIRE FRANCAIS DU FRACTIONNEMENT DES BIOTECHNOLOGIES·Filed 2016·Granted Jan 15, 2019·3 cites·20 claims
- 0671US9511138B2Pharmaceutical compositions comprising an antibody which binds the human anti-mullerian hormone receptor type IILFB BIOTECHNOLOGIES·Filed 2012·Granted Dec 6, 2016·2 cites·24 claims
- 0766US8038993B2Cytotoxic antibodies directed against antibodies inhibiting factor VIIILFB BIOTECHNOLOGIES·Filed 2006·Granted Oct 18, 2011·0 cites·11 claims
- 0861US9109020B2Use of ADCC-optimized antibodies for treating weak patientsLAB FRANCAIS DU FRACTIONNEMENT·Filed 2013·Granted Aug 18, 2015·0 cites·10 claims
- 0958US2010323368A1Cytokine production-inducing antibodyLAB FRANCAIS DU FRACTIONNEMENT·Filed 2009·Application pending·0 cites
- 1057US2009081216A1Treatment of pathologies which escape the immune response, using optimized antibodiesLAB FRANCAIS DU FRACTIONNEMENT·Filed 2008·Application pending·0 cites
- 1156US7595165B2Method of measuring activation of effector cellsLAB FRANCAIS DU FRACTIONNEMENT·Filed 2003·Granted Sep 29, 2009·2 cites·1 claims
- 1254US9879089B2Use of ADCC-optimized antibodies for treating low-responder patientsLAB FRANCAIS DU FRACTIONNEMENT·Filed 2015·Granted Jan 30, 2018·0 cites·14 claims
- 1350US2005271652A1Treatment of pathologies which escape the immune response, using optimised antibodiesLAB FRANCAIS DU FRACTIONNEMENT·Filed 2003·Application pending·0 cites
- 1448US2011274684A1Cytotoxic antibodies directed against antibodies inhibiting factor viiiLFB BIOTECHNOLOGIES·Filed 2011·Application pending·0 cites
- 1543US2009175789A1Antibody raised against the ldl receptorLFB BIOTECHNOLOGIES·Filed 2006·Application pending·0 cites
- 1640US2019270801A1Oral Composition of Anti-TNF-Alpha AntibodiesLAB FRANCAIS DU FRACTIONNEMENT·Filed 2017·Application pending·0 cites
- 1736US8404241B2Anti-rhesus D monoclonal antibodyGAUCHER CHRISTINE·Filed 2010·Granted Mar 26, 2013·0 cites·20 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →